Four companies in IPO quintet post first-day gains
Four of the five biopharmas that priced IPOs late Wednesday posted gains on Thursday. Cell therapy company Avrobio Inc. (NASDAQ:AVRO) had the biggest first-day bump, climbing $12.20 (64%) to $31.20, while three others posted double-digit gains.
The five raised a total of more than $460 million. Four of the five upsized their offerings to sell more shares than anticipated; one of